Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2014

Open Access 01-05-2014 | Oral presentation

Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms

Authors: Beatrix Kotlan, Gabriella Liszkay, Gyorgy Naszados, Judit Olasz, Szabolcs Horvath, Klara Eles, Miri Blank, Yehuda Shoenfeld, Laszlo Gobor, Laszlo Toth, Orsolya Csuka, Maria Godeny, Miklos Kasler, Francesco M Marincola

Published in: Journal of Translational Medicine | Special Issue 1/2014

Login to get access

Excerpt

To determine whether the growth of tumors is sustained by the whole cancer cell population or it is maintained only by small fraction of cancer initiating cells, has crucial impact on the design of suitable therapies. That is why the research on defining the subpopulation of cancer initiating cancer stem cells (CSC) in solid tumors has come into highlights. …
Metadata
Title
Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms
Authors
Beatrix Kotlan
Gabriella Liszkay
Gyorgy Naszados
Judit Olasz
Szabolcs Horvath
Klara Eles
Miri Blank
Yehuda Shoenfeld
Laszlo Gobor
Laszlo Toth
Orsolya Csuka
Maria Godeny
Miklos Kasler
Francesco M Marincola
Publication date
01-05-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-S1-O1

Other articles of this Special Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue

Poster presentation

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma

Oral presentation

Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma

Poster presentation

Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results

Oral presentation

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Poster presentation

Natural immunomodulator preimplantation factor PIF affected cancer growth in malignant melanomas

Oral presentation

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits